GSK Plc (GSK)
54.51
-0.76
(-1.38%)
USD |
NYSE |
Mar 06, 16:00
54.50
-0.01
(-0.02%)
Pre-Market: 20:00
GSK SG&A Expense (TTM) : 11.99B for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| AstraZeneca PLC | 580.07M |
| Biodexa Pharmaceuticals Plc | 5.354M |
| Mereo BioPharma Group Plc | 25.26M |
| Rapt Therapeutics, Inc. | 29.76M |
| Moderna, Inc. | 1.018B |